Clinical presentation and diagnosis of imported strongyloidiasis at a tertiary hospital, Stockholm, Sweden
Copyright © 2023 The Authors. Published by Elsevier Ltd.. All rights reserved..
BACKGROUND: Since Strongyloides can persist in its host for decades, and cause life threatening infections data on prevalence, the burden and risk factors for infection is crucial in migrant populations.
METHODS: In this observational retrospective cohort study, we describe the epidemiological, clinical, and microbiological characteristics of imported strongyloidiasis diagnosed at the Karolinska University Hospital, Stockholm, Sweden, during 2010-2021.
RESULTS: We identified 98 individuals with strongyloidiasis, 89 (90.8%) born in endemic and 9 (9.2%) in non-endemic countries. Sub-Saharan Africa was the most common origin among the group born in endemic countries (62, 69.7%), (p < 0.005). There were 22 individuals with an underlying immunosuppressive condition. Gastrointestinal symptoms (53/98, 54.1%) were the symptoms most frequently described, and were more frequent in adults (57.0%) vs children (0%) (p = 0.013). Eosinophilia was detected in 74 (75.5%), being more frequent in the endemic-borne group (79.8% vs 33.3%, p = 0.002). Eight persons developed complications of strongyloidiasis because of either hyperinfection or disseminated disease. No people living with HIV with CD4 <500/mm3 (n = 6) developed severe strongyloidiasis.
CONCLUSION: A limited number of strongyloidiasis cases was identified, with few complicated cases in immunosuppressed patients. Further studies focusing on identifying and exploring the risk of complicated strongyloidiasis in immunosuppressed patients are needed.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:56 |
---|---|
Enthalten in: |
Travel medicine and infectious disease - 56(2023) vom: 01. Nov., Seite 102666 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Requena-Méndez, Ana [VerfasserIn] |
---|
Links: |
---|
Themen: |
Journal Article |
---|
Anmerkungen: |
Date Completed 05.01.2024 Date Revised 11.03.2024 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1016/j.tmaid.2023.102666 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM36468772X |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM36468772X | ||
003 | DE-627 | ||
005 | 20240311231951.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.tmaid.2023.102666 |2 doi | |
028 | 5 | 2 | |a pubmed24n1323.xml |
035 | |a (DE-627)NLM36468772X | ||
035 | |a (NLM)37977232 | ||
035 | |a (PII)S1477-8939(23)00126-6 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Requena-Méndez, Ana |e verfasserin |4 aut | |
245 | 1 | 0 | |a Clinical presentation and diagnosis of imported strongyloidiasis at a tertiary hospital, Stockholm, Sweden |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 05.01.2024 | ||
500 | |a Date Revised 11.03.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2023 The Authors. Published by Elsevier Ltd.. All rights reserved. | ||
520 | |a BACKGROUND: Since Strongyloides can persist in its host for decades, and cause life threatening infections data on prevalence, the burden and risk factors for infection is crucial in migrant populations | ||
520 | |a METHODS: In this observational retrospective cohort study, we describe the epidemiological, clinical, and microbiological characteristics of imported strongyloidiasis diagnosed at the Karolinska University Hospital, Stockholm, Sweden, during 2010-2021 | ||
520 | |a RESULTS: We identified 98 individuals with strongyloidiasis, 89 (90.8%) born in endemic and 9 (9.2%) in non-endemic countries. Sub-Saharan Africa was the most common origin among the group born in endemic countries (62, 69.7%), (p < 0.005). There were 22 individuals with an underlying immunosuppressive condition. Gastrointestinal symptoms (53/98, 54.1%) were the symptoms most frequently described, and were more frequent in adults (57.0%) vs children (0%) (p = 0.013). Eosinophilia was detected in 74 (75.5%), being more frequent in the endemic-borne group (79.8% vs 33.3%, p = 0.002). Eight persons developed complications of strongyloidiasis because of either hyperinfection or disseminated disease. No people living with HIV with CD4 <500/mm3 (n = 6) developed severe strongyloidiasis | ||
520 | |a CONCLUSION: A limited number of strongyloidiasis cases was identified, with few complicated cases in immunosuppressed patients. Further studies focusing on identifying and exploring the risk of complicated strongyloidiasis in immunosuppressed patients are needed | ||
650 | 4 | |a Observational Study | |
650 | 4 | |a Journal Article | |
650 | 4 | |a Migrants | |
650 | 4 | |a PCR | |
650 | 4 | |a Serology | |
650 | 4 | |a Strongyloides | |
650 | 4 | |a Sweden | |
650 | 4 | |a Travellers | |
700 | 1 | |a Roos, Emilia |e verfasserin |4 aut | |
700 | 1 | |a van der Werff, Suzanne D |e verfasserin |4 aut | |
700 | 1 | |a Wyss, Katja |e verfasserin |4 aut | |
700 | 1 | |a Davidsson, Leigh |e verfasserin |4 aut | |
700 | 1 | |a Naucler, Pontus |e verfasserin |4 aut | |
700 | 1 | |a Färnert, Anna |e verfasserin |4 aut | |
700 | 1 | |a Asgeirsson, Hilmir |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Travel medicine and infectious disease |d 2003 |g 56(2023) vom: 01. Nov., Seite 102666 |w (DE-627)NLM16457655X |x 1873-0442 |7 nnns |
773 | 1 | 8 | |g volume:56 |g year:2023 |g day:01 |g month:11 |g pages:102666 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.tmaid.2023.102666 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 56 |j 2023 |b 01 |c 11 |h 102666 |